Ben E. Evans
42Patents
18h-index
25Co-inventors
81Inventor score
Filing activity: Aug 10, 1976 → Sep 27, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4668770A | Renin inhibitory tripeptides | Emerging Cross-Sectional Technologies | 156 | Expired |
| US4820834A | Benzodiazepine analogs | Human Necessities | 114 | Expired |
| US5324726A | Benzodiazepine analogs | Human Necessities | 90 | Expired |
| US5464788A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 78 | Expired |
| US5756504A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 58 | Expired |
| US5206234A | Benzolactam analogs as antagonists of CCK | Human Necessities | 46 | Expired |
| US4755508A | Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin | Chemistry; Metallurgy | 45 | Expired |
| US5004741A | Methods of antagonizing CCK or gastrin with benzodiazepine analogs | Human Necessities | 43 | Expired |
| US5091387A | Spirocyclic oxytocin antagonists | Chemistry; Metallurgy | 43 | Expired |
| US5665719A | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 40 | Expired |
| US5166151A | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof | Chemistry; Metallurgy | 36 | Expired |
| US5177071A | 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder | Human Necessities | 31 | Expired |
| US5693643A | Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists | Chemistry; Metallurgy | 28 | Expired |
| US5175159A | 3-substituted-1,4-benzodiazepines as oxytocin antagonists | Chemistry; Metallurgy | 27 | Expired |
| US4812442A | Tripeptide renin inhibitors | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5670509A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 21 | Expired |
| US5210082A | 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders | Human Necessities | 20 | Expired |
| US5185331A | Triazolobenzodiazepines | Human Necessities | 20 | Expired |
| US4684646A | 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists | Human Necessities | 18 | Expired |
| US4636491A | Renin inhibitory peptides having improved solubility | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4665055A | Peptide renin inhibitors | Emerging Cross-Sectional Technologies | 15 | Expired |
| US4374838A | Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines | Chemistry; Metallurgy | 15 | Expired |
| US4399141A | 5-Alkyl or hydroxyalkyl substituted-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines and anticonvulsant use thereof | Chemistry; Metallurgy | 14 | Expired |
| US4847248A | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists | Chemistry; Metallurgy | 14 | Expired |
| US4663321A | Triazolobenzodiazepines and pharmaceutical use | Chemistry; Metallurgy | 12 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.